Red blood cell alloimmunization in transfusion‐dependent Egyptian patients with thalassemia in a limited donor exposure program
BACKGROUND: Thalassemia is considered the most common hemoglobinopathy in Egypt
and is one of its major health problems. Lifelong red blood cell (RBC) transfusion remains …
and is one of its major health problems. Lifelong red blood cell (RBC) transfusion remains …
Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan
U Zaidi, M Borhany, S Ansari, S Parveen… - Transfusion …, 2015 - Wiley Online Library
SUMMARY Background In Pakistan routine blood group typing of thalassemia patients
identifies ABO and Rh (D) antigens only. Therefore, other antigen incompatibilities between …
identifies ABO and Rh (D) antigens only. Therefore, other antigen incompatibilities between …
A study of red blood cell alloimmunization and autoimmunization among 200 multitransfused Egyptian β thalassemia patients
A El-Beshlawy, AA Salama, MR El-Masry… - Scientific Reports, 2020 - nature.com
The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …
Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt
AM Abdelrazik, SM Elshafie, MN El Said… - …, 2016 - Wiley Online Library
BACKGROUND β‐Thalassemia is considered the most common chronic hemolytic anemia
in Egypt. Alloimmunization can lead to serious clinical complications in transfusion …
in Egypt. Alloimmunization can lead to serious clinical complications in transfusion …
Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review
CK Cheng, CK Lee, CK Lin - Transfusion, 2012 - Wiley Online Library
BACKGROUND: Red blood cell (RBC) alloimmunization is reported to occur at an incidence
of 5.2% to 23.5% among patients with thalassemia requiring chronic transfusion. With very …
of 5.2% to 23.5% among patients with thalassemia requiring chronic transfusion. With very …
Alloimmunization among transfusion-dependent thalassemia patients
MH Sadeghian, MR Keramati, Z Badiei… - Asian journal of …, 2009 - journals.lww.com
Background: Thalassemia is a common hemoglobin disorder in Iran and one of the major
public health problems. Although blood transfusions are lifesavers for thalassemia patients …
public health problems. Although blood transfusions are lifesavers for thalassemia patients …
Frequency and specificity of red cell antibodies in thalassemia patients in Albania
I Seferi, M Xhetani, M Face, G Burazeri… - … journal of laboratory …, 2015 - Wiley Online Library
Introduction Thalassemia major is a common hemoglobinopathy in Albania. However, there
are no data available on the frequency of RBC alloimmunization and autoimmunization in …
are no data available on the frequency of RBC alloimmunization and autoimmunization in …
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
Background: The development of anti-red blood cell antibodies (both allo-and
autoantibodies) remains a major problem in thalassemia major patients. We studied the …
autoantibodies) remains a major problem in thalassemia major patients. We studied the …
Detection and identification of red cell alloantibodies in multiply transfused thalassemia major patients: A prospective study
R Jain, N Choudhury, U Chudgar… - Indian Journal of …, 2014 - Springer
Life long red blood transfusion remains the main treatment for β thalassemia major patients.
The development of alloantibodies complicates transfusion therapy in thalassemia patients …
The development of alloantibodies complicates transfusion therapy in thalassemia patients …
Antibody screening in patients with thalassemia major
Background: The development of hemolytic alloantibodies and erythrocyte autoantibodies
complicates transfusion therapy in thalassemia patients. Methods: The frequency, causes …
complicates transfusion therapy in thalassemia patients. Methods: The frequency, causes …